Literature DB >> 20813412

Cannabis users differ from non-users on measures of personality and schizotypy.

Daniel J Fridberg1, Jennifer M Vollmer, Brian F O'Donnell, Patrick D Skosnik.   

Abstract

Accumulating evidence indicates that cannabis use may be a risk factor for schizophrenia (SZ), and chronic cannabis users score higher than non-users on measures of schizotypal personality traits. The purpose of the present study was to investigate the relations between normal personality, schizotypy, and cannabis use. Sixty-two chronic cannabis users and 45 cannabis-naïve controls completed a measure of normal personality, the NEO-Five Factor Inventory (NEO-FFI), and two measures of schizotypy, the schizotypal personality questionnaire (SPQ) and perceptual aberration scale (PAS). Substance use was assessed using the SCID I alcohol/drug module and a locally developed drug use questionnaire. On the NEO-FFI, users scored higher than controls on openness, but lower on agreeableness and conscientiousness, and endorsed greater schizotypy on the SPQ and PAS. Higher neuroticism predicted greater schizotypy in both groups, and, higher Extraversion predicted lower negative-syndrome schizotypy among users. Finally, duration of cannabis use was positively correlated with scores on the SPQ and PAS among users, suggesting a relation between overall cannabis use chronicity and schizotypy. These data show that cannabis users differ from non-users on dimensions of normal personality and schizotypy, and provide further evidence that cannabis use is associated with increased levels of psychosis-related personality traits.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 20813412      PMCID: PMC3036782          DOI: 10.1016/j.psychres.2010.07.035

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  50 in total

1.  Cannabis use is associated with schizotypy and attentional disinhibition.

Authors:  P D Skosnik; L Spatz-Glenn; S Park
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Increased use of marijuana and other illicit drugs at US colleges in the 1990s: results of three national surveys.

Authors:  J Gledhill-Hoyt; H Lee; J Strote; H Wechsler
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

3.  Cannabis use correlates with schizotypal personality traits in healthy students.

Authors:  Patrick Dumas; Mohamed Saoud; Sébastien Bouafia; Christel Gutknecht; René Ecochard; Jean Daléry; Thierry Rochet; Thierry d'Amato
Journal:  Psychiatry Res       Date:  2002-01-31       Impact factor: 3.222

4.  Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects.

Authors:  R Mass; C Bardong; K Kindl; B Dahme
Journal:  Psychopathology       Date:  2001 Jul-Aug       Impact factor: 1.944

5.  Positive and negative symptoms of schizotypy and the Five-factor model: a domain and facet level analysis.

Authors:  Scott R Ross; Catherine J Lutz; Steven E Bailley
Journal:  J Pers Assess       Date:  2002-08

6.  Cannabis use and dimensions of psychosis in a nonclinical population of female subjects.

Authors:  Hélène Verdoux; F Sorbara; C Gindre; Joël D Swendsen; Jim van Os
Journal:  Schizophr Res       Date:  2003-01-01       Impact factor: 4.939

7.  Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-Risk Study.

Authors:  Patrick Miller; Majella Byrne; Ann Hodges; Stephen M Lawrie; David G C Owens; Eve C Johnstone
Journal:  Br J Psychiatry       Date:  2002-02       Impact factor: 9.319

Review 8.  The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches.

Authors:  J A Lieberman; D Perkins; A Belger; M Chakos; F Jarskog; K Boteva; J Gilmore
Journal:  Biol Psychiatry       Date:  2001-12-01       Impact factor: 13.382

9.  Neuroticism as a risk factor for schizophrenia.

Authors:  J Van Os; P B Jones
Journal:  Psychol Med       Date:  2001-08       Impact factor: 7.723

10.  Neuroticism and low self-esteem as risk factors for psychosis.

Authors:  Lydia Krabbendam; Ilse Janssen; Maarten Bak; Rob V Bijl; Ron de Graaf; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2002-01       Impact factor: 4.328

View more
  27 in total

1.  Neuropsychological effects associated with recreational cocaine use.

Authors:  Kirstie Soar; Colette Mason; Anita Potton; Lynne Dawkins
Journal:  Psychopharmacology (Berl)       Date:  2012-02-29       Impact factor: 4.530

2.  Structural network topology revealed by white matter tractography in cannabis users: a graph theoretical analysis.

Authors:  Dae-Jin Kim; Patrick D Skosnik; Hu Cheng; Ben J Pruce; Margaret S Brumbaugh; Jennifer M Vollmer; William P Hetrick; Brian F O'Donnell; Olaf Sporns; Aina Puce; Sharlene D Newman
Journal:  Brain Connect       Date:  2012-02-24

3.  The effect of chronic cannabinoids on broadband EEG neural oscillations in humans.

Authors:  Patrick D Skosnik; Deepak C D'Souza; Adam B Steinmetz; Chad R Edwards; Jennifer M Vollmer; William P Hetrick; Brian F O'Donnell
Journal:  Neuropsychopharmacology       Date:  2012-06-20       Impact factor: 7.853

4.  Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.

Authors:  Deborah Hasin; Miriam C Fenton; Andrew Skodol; Robert Krueger; Katherine Keyes; Timothy Geier; Eliana Greenstein; Carlos Blanco; Bridget Grant
Journal:  Arch Gen Psychiatry       Date:  2011-11

5.  Cannabis and alcohol use, affect and impulsivity in psychiatric out-patients' daily lives.

Authors:  Timothy J Trull; Andrea M Wycoff; Sean P Lane; Ryan W Carpenter; Whitney C Brown
Journal:  Addiction       Date:  2016-07-24       Impact factor: 6.526

6.  Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.

Authors:  Patrick D Skosnik; Giri P Krishnan; Deepak C D'Souza; William P Hetrick; Brian F O'Donnell
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

7.  Personality and externalizing behavior in the transition to young adulthood: the additive value of personality facets.

Authors:  Theo A Klimstra; Koen Luyckx; William W Hale Iii; Luc Goossens
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-31       Impact factor: 4.328

8.  Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis.

Authors:  H Cheng; P D Skosnik; B J Pruce; M S Brumbaugh; J M Vollmer; D J Fridberg; B F O'Donnell; W P Hetrick; S D Newman
Journal:  J Psychopharmacol       Date:  2014-09-18       Impact factor: 4.153

9.  Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.

Authors:  Marco Colizzi; Conrad Iyegbe; John Powell; Gianluca Ursini; Annamaria Porcelli; Aurora Bonvino; Paolo Taurisano; Raffaella Romano; Rita Masellis; Giuseppe Blasi; Craig Morgan; Katherine Aitchison; Valeria Mondelli; Sonija Luzi; Anna Kolliakou; Anthony David; Robin M Murray; Alessandro Bertolino; Marta Di Forti
Journal:  Schizophr Bull       Date:  2015-03-31       Impact factor: 9.306

10.  Neural correlates of performance monitoring in chronic cannabis users and cannabis-naive controls.

Authors:  Daniel J Fridberg; Patrick D Skosnik; William P Hetrick; Brian F O'Donnell
Journal:  J Psychopharmacol       Date:  2013-02-20       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.